GB Meka
Stocks to watch

DFTX

Compare

DEFINIUM THERAPEUTICS INC · Healthcare

$38.06
▼ 0.4%Close 2026-09-30

Live intraday price

Compare with our price levels

T243.77
T141.50
E129.92
E321.69
SL19.53

Close 2026-09-30: $38.06 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▲ Leaning positive

Not in the buy zone yet — needs to drop 21.4% · 2 whales recently bought

1 month
▼ 4.2%
3 months
▼ 12.3%
1 year
▲ 216.1%
Analyst target
$71.65 +88.2%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$29.92 -21.4%
E2$27.03 -29.0%
E3$21.69 -43.0%
Targets
T1$41.50 9.1%
T2$43.77 15.0%
T3$45.42 19.3%
Stop-loss
SL$19.53 -48.7%
Whale cost ~$29.92 -21.4%

Risk : reward 1 : 2.6Moves ~$2.16 a day

⚖️ Positives and risks

✓ Positives (6)
  • ●2 whales bought or added last quarter
  • ●Long-term uptrend (above a rising MA200)
  • ●MACD just crossed up (momentum turning positive)
  • ●Beat the market (S&P 500) by +84% over 6 months
  • ●Average analyst price target 71.65 (upside +88%, 17 analysts)
  • ●Most analysts rate it Strong Buy
! Risks (1)
  • ●Price is +40% above MA200 — already ran a lot

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Barrow Robert · CEO · Director

2026-09-25 · 31,550 shares @ $36.57 · pre-planned sale (10b5-1)

$1M
Sell

Sullivan Mark · Officer

2026-09-25 · 14,051 shares @ $36.57 · pre-planned sale (10b5-1)

$513,845
Sell

Karlin Daniel · Director

2026-09-25 · 10,853 shares @ $36.57 · pre-planned sale (10b5-1)

$396,894
Sell

Roberts Brandi · CFO

2026-09-25 · 3,377 shares @ $36.57 · pre-planned sale (10b5-1)

$123,497
Sell

Wiley Matthew T. · Officer

2026-09-25 · 3,097 shares @ $36.57 · pre-planned sale (10b5-1)

$113,257
Sell

Barrow Robert · CEO · Director

2026-09-03 · 19,023 shares @ $37.94 · pre-planned sale (10b5-1)

$721,733
Sell

Barrow Robert · CEO · Director

2026-06-25 · 29,208 shares @ $45.03 · pre-planned sale (10b5-1)

$1M
Sell

Sullivan Mark · Officer

2026-06-25 · 13,008 shares @ $45.03 · pre-planned sale (10b5-1)

$585,750
Sell

Karlin Daniel · Officer

2026-06-25 · 10,035 shares @ $45.03 · pre-planned sale (10b5-1)

$451,876
Sell

Roberts Brandi · CFO

2026-06-25 · 3,013 shares @ $45.03 · pre-planned sale (10b5-1)

$135,675
Sell

Wiley Matthew T. · Officer

2026-06-25 · 2,867 shares @ $45.03 · pre-planned sale (10b5-1)

$129,101
Sell

Barrow Robert · CEO · Director

2026-03-25 · 24,431 shares @ $18.47 · pre-planned sale (10b5-1)

$451,241
Sell

Sullivan Mark · Officer

2026-03-25 · 10,702 shares @ $18.47 · pre-planned sale (10b5-1)

$197,666
Sell

Karlin Daniel · Officer

2026-03-25 · 8,018 shares @ $18.47 · pre-planned sale (10b5-1)

$148,092
Sell

Barrow Robert · CEO · Director

2025-12-26 · 25,791 shares @ $13.15 · pre-planned sale (10b5-1)

$339,072

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-08-06Miss -162%

Actual EPS -$1.44 · est. -$0.55 · After close

▲ 0.0%

Day 1

-17.4%

Next 20 days

2026-05-07Miss -44%

Actual EPS -$0.71 · est. -$0.49 · After close

▼ 5.0%

Day 1

+4.4%

Next 20 days

2026-02-26In line -2%

Actual EPS -$0.50 · est. -$0.49 · After close

▲ 0.9%

Day 1

+2.5%

Next 20 days

2025-11-06Miss -55%

Actual EPS -$0.78 · est. -$0.50 · After close

▲ 3.2%

Day 1

+11.1%

Next 20 days

2025-07-31Miss -38%

Actual EPS -$0.50 · est. -$0.36 · After close

▼ 7.2%

Day 1

+5.2%

Next 20 days

2025-05-08In line +4%

Actual EPS -$0.35 · est. -$0.37 · Before open

▼ 2.0%

Day 1

+20.6%

Next 20 days

2025-03-06Miss -47%

Actual EPS -$0.41 · est. -$0.28 · Before open

▲ 3.6%

Day 1

-16.0%

Next 20 days

2024-11-07Beat +32%

Actual EPS -$0.18 · est. -$0.26 · After close

▲ 12.9%

Day 1

-14.2%

Next 20 days

Listen to the earnings call or read the full report on DFTX's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$4.9B
Next earnings2026-11-05
P/E (price to earnings)-
Forward P/E (on expected earnings)-19.0
Revenue growth (YoY)-
Earnings growth (YoY)-
Net profit margin0.0%
ROE-64.1%
Debt to equity (D/E)4%
Dividend yield-
Analyst targets (high / low)$91.00 / $55.00
Number of analysts17
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Downtrend ↘ · Uptrend ↗
RSI46
MA50 / MA200$41.36 / $27.16
Distance from MA200+40.1%
MACDJust crossed up
1-year high / low$49.70 / $10.47
vs. S&P 500 (6 months)+83.5%
Volume vs. average1.02×